[go: up one dir, main page]

GB2332626B - Medicaments for treatment of disorders of the middle ear - Google Patents

Medicaments for treatment of disorders of the middle ear

Info

Publication number
GB2332626B
GB2332626B GB9825973A GB9825973A GB2332626B GB 2332626 B GB2332626 B GB 2332626B GB 9825973 A GB9825973 A GB 9825973A GB 9825973 A GB9825973 A GB 9825973A GB 2332626 B GB2332626 B GB 2332626B
Authority
GB
United Kingdom
Prior art keywords
medicaments
disorders
treatment
middle ear
ear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9825973A
Other versions
GB2332626A (en
GB2332626A9 (en
GB9825973D0 (en
Inventor
Derek Alan Woodcock
Brian Andrew Hills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Britannia Pharmaceuticals Ltd
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of GB2332626A9 publication Critical patent/GB2332626A9/en
Priority claimed from GBGB9727275.1A external-priority patent/GB9727275D0/en
Priority claimed from GBGB9801328.7A external-priority patent/GB9801328D0/en
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Priority to GB9825973A priority Critical patent/GB2332626B/en
Publication of GB9825973D0 publication Critical patent/GB9825973D0/en
Publication of GB2332626A publication Critical patent/GB2332626A/en
Application granted granted Critical
Publication of GB2332626B publication Critical patent/GB2332626B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9825973A 1997-12-24 1998-11-26 Medicaments for treatment of disorders of the middle ear Expired - Fee Related GB2332626B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9825973A GB2332626B (en) 1997-12-24 1998-11-26 Medicaments for treatment of disorders of the middle ear

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9727275.1A GB9727275D0 (en) 1997-12-24 1997-12-24 Medicaments for treatment of disorders of the middle ear
GBGB9801328.7A GB9801328D0 (en) 1998-01-21 1998-01-21 Medicaments for treatment of disorders of the middle ear
GB9825973A GB2332626B (en) 1997-12-24 1998-11-26 Medicaments for treatment of disorders of the middle ear

Publications (4)

Publication Number Publication Date
GB2332626A9 GB2332626A9 (en)
GB9825973D0 GB9825973D0 (en) 1999-01-20
GB2332626A GB2332626A (en) 1999-06-30
GB2332626B true GB2332626B (en) 2002-07-03

Family

ID=27269157

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9825973A Expired - Fee Related GB2332626B (en) 1997-12-24 1998-11-26 Medicaments for treatment of disorders of the middle ear

Country Status (1)

Country Link
GB (1) GB2332626B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870174A (en) * 1986-08-07 1989-09-26 Medice Chem.-Pharm. Fabrik Imidozopyrionidines and their use in pharmaceutical preparations
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870174A (en) * 1986-08-07 1989-09-26 Medice Chem.-Pharm. Fabrik Imidozopyrionidines and their use in pharmaceutical preparations
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Am. J. Otolaryngol. 1989, 10(5), 301-4, (P. White) "Effect of ......in the Rat" *
Arch. Otolaryngol. 1984, 110(1), 3-9 (B.A. Hills) "Analysis ......as a Release Agent" *

Also Published As

Publication number Publication date
GB2332626A (en) 1999-06-30
GB2332626A9 (en)
GB9825973D0 (en) 1999-01-20

Similar Documents

Publication Publication Date Title
EP1063990A4 (en) Therapy of estrogen-associated disorders
IL121170A0 (en) Compositions for the treatment of dermatological disorders
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
PL339425A1 (en) Treatment of behavioural disorders
AU3673499A (en) Hydrogel for the therapeutic treatment of aneurysms
IL133800A0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
HUP9904525A3 (en) Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan
EP1007028A4 (en) 8-iso-prostaglandins for glaucoma therapy
AU2058697A (en) Treatment of sleep disorders
EP1126850A4 (en) Treatment of disorders of the outer retina
GB9926968D0 (en) Treatment of neurological disorders
AU7106300A (en) Treatment of skin disorders
AUPM456894A0 (en) Treatment for gastric disorders
IL131347A0 (en) Treatment of skin disorders
AU7449698A (en) Therapeutic agents for respiratory diseases
IL135994A0 (en) Combination therapy for the treatment of aids
IL120005A (en) Pharmaceutical compositions for the treatment of the eye
GB2332626B (en) Medicaments for treatment of disorders of the middle ear
GB9727275D0 (en) Medicaments for treatment of disorders of the middle ear
GB9801328D0 (en) Medicaments for treatment of disorders of the middle ear
GB0020261D0 (en) Therapeutic treatment
ZA985818B (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
AU3190595A (en) Corneal therapeutic agent
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders
AU2003204277A1 (en) Treatment of hematologic disorders

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20051126